Literature DB >> 18216764

Effects of remifentanil on propofol requirements for loss of consciousness in target-controlled infusion.

Y S Jee1, J Y Hong.   

Abstract

BACKGROUND: We evaluated the effects of various doses of target-controlled remifentanil on the propofol requirements for the loss of consciousness (LOC) and the consequent hemodynamic changes on the induction of intravenous anesthesia in day-case surgery.
METHODS: Eighty infertile female patients scheduled for diagnostic laparoscopy were randomly allocated to 1 of 4 groups (20 in each) to receive a target concentration of 1 ng x mL(-1) (Remi-1 group), 2 ng x mL(-1) (Remi-2 group), 3 ng x mL(-1) (Remi-3 group), or 4 ng x mL(-1) remifentanil (Remi-4 group). After equilibrium of remifentanil, propofol was administered with initial target concentration of 2 microg x mL(-1) and with 1 microg x mL(-1) increments. The response to call was assessed every 15 s until a LOC was achieved.
RESULTS: The effect site concentration of propofol (Ce), the total propofol dose, and the time for LOC were significantly decreased with increasing remifentanil concentrations. There was a moderate correlation between the effect of remifentanil and the effect site concentration of propofol at the LOC (r(2) = 0.353, P < 0.05). There was also a moderate correlation between the remifentanil concentration and the time to LOC (r(2) = 0.442, P < 0.05). There were no significant differences in the hemodynamics among the groups, although the decreases in blood pressure after propofol administration in all groups were significant compared with baseline.
CONCLUSION: The effect of altering the target-controlled remifentanil concentration during propofol induction was found to be dose-dependent. There was no significant difference in the cardiovascular response with the studied range of concentrations of remifentanil and propofol.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216764

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  3 in total

1.  Ideal body weight-based remifentanil infusion is potentially insufficient for anesthetic induction in mildly obese patients.

Authors:  Takayuki Kunisawa; Sayuri Mitamura; Satoshi Hanada; Akihiro Suzuki; Osamu Takahata; Hiroshi Iwasaki
Journal:  J Anesth       Date:  2012-05-03       Impact factor: 2.078

2.  Comparison of the effect of continuous intravenous infusion and two bolus injections of remifentanil on haemodynamic responses during anaesthesia induction: a prospective randomised single-centre study.

Authors:  Toyoaki Maruta; Yoshihumi Kodama; Ishie Tanaka; Tetsuro Shirasaka; Isao Tsuneyoshi
Journal:  BMC Anesthesiol       Date:  2016-11-14       Impact factor: 2.217

3.  Remifentanil use in pediatric scoliosis surgery-an effective alternative to morphine (a retrospective study).

Authors:  Ibrahim Abu-Kishk; Roei Hod-Feins; Yoram Anekstein; Yigal Mirovsky; Josi Barr; Eli Lahat; Gideon Eshel
Journal:  Yonsei Med J       Date:  2012-09       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.